Beck Capital Management LLC reduced its stake in Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 36.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,042 shares of the company's stock after selling 90,380 shares during the quarter. Beck Capital Management LLC owned about 0.24% of Global Medical REIT worth $1,566,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of GMRE. Bank of New York Mellon Corp boosted its position in shares of Global Medical REIT by 78.5% in the second quarter. Bank of New York Mellon Corp now owns 1,183,477 shares of the company's stock valued at $10,746,000 after acquiring an additional 520,583 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Global Medical REIT by 788.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 130,560 shares of the company's stock worth $1,143,000 after purchasing an additional 115,866 shares in the last quarter. AQR Capital Management LLC raised its stake in Global Medical REIT by 71.1% in the 2nd quarter. AQR Capital Management LLC now owns 188,931 shares of the company's stock worth $1,715,000 after purchasing an additional 78,528 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Global Medical REIT by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 6,213,404 shares of the company's stock valued at $54,367,000 after purchasing an additional 76,267 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Global Medical REIT by 158.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company's stock worth $1,195,000 after purchasing an additional 73,965 shares in the last quarter. 57.52% of the stock is currently owned by institutional investors and hedge funds.
Global Medical REIT Price Performance
Shares of NYSE:GMRE traded down $0.11 during midday trading on Monday, hitting $8.78. The stock had a trading volume of 366,729 shares, compared to its average volume of 383,214. The company's 50-day moving average price is $9.22 and its 200-day moving average price is $9.24. Global Medical REIT Inc. has a fifty-two week low of $7.98 and a fifty-two week high of $11.59. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The company has a market capitalization of $586.50 million, a P/E ratio of -444.28, a price-to-earnings-growth ratio of 1.53 and a beta of 1.25.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.18). Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The firm had revenue of $34.26 million for the quarter, compared to analyst estimates of $34.88 million. During the same quarter in the prior year, the firm earned $0.23 earnings per share. As a group, equities research analysts predict that Global Medical REIT Inc. will post 0.83 EPS for the current fiscal year.
Global Medical REIT Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, October 8th. Investors of record on Friday, September 20th were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 9.57%. The ex-dividend date of this dividend was Friday, September 20th. Global Medical REIT's dividend payout ratio (DPR) is presently -4,197.90%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on GMRE shares. Berenberg Bank started coverage on shares of Global Medical REIT in a research report on Friday, October 18th. They issued a "buy" rating and a $11.75 price target for the company. Alliance Global Partners assumed coverage on Global Medical REIT in a report on Thursday, September 19th. They issued a "buy" rating and a $12.00 price objective for the company.
Check Out Our Latest Research Report on GMRE
About Global Medical REIT
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Articles
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.